首页> 外文期刊>Nature >The SUMO modification pathway is involved in the BRCA1 response to genotoxic stress
【24h】

The SUMO modification pathway is involved in the BRCA1 response to genotoxic stress

机译:SUMO修饰途径参与BRCA1对遗传毒性胁迫的反应

获取原文
获取原文并翻译 | 示例
       

摘要

Mutations in BRCA1 are associated with a high risk of breast and ovarian cancer. 6RCA1 participates in the DNA damage response and acts as a ubiquitin ligase. However, its regulation remains poorly understood. Here we report that BRCA1 is modified by small ubiquitin-like modifier (SUMO) in response to genotoxic stress, and co-localizes at sites of DNA damage with SUM01, SUMO2/3 and the SUMO-conjugating enzyme Ubc9. PIAS SUMO E3 ligases co-localize with and modulate SUMO modification of BRCA1, and are required for BRCA1 ubiquitin ligase activity in cells. In vitro SUMO modification of the BRCA1/BARD1 heterodimer greatly increases its ligase activity, identifying it as a SUMO-regulated ubiquitin ligase (SRUbL). Further, PIAS SUMO ligases are required for complete accumulation of double-stranded DNA (dsDNA) damage-repair proteins subsequent to RNF8 accrual, and for proficient double-strand break repair. These data demonstrate that the SUMOylation pathway plays a significant role in mammalian DNA damage response.
机译:BRCA1中的突变与乳腺癌和卵巢癌的高风险有关。 6RCA1参与DNA损伤反应并充当泛素连接酶。但是,其法规仍然知之甚少。在这里我们报告说,BRCA1被小泛素样修饰剂(SUMO)修饰,以应对遗传毒性胁迫,并共定位于SUM01,SUMO2 / 3和SUMO缀合酶Ubc9对DNA损伤的位点。 PIAS SUMO E3连接酶与BRCA1共定位并调节BRCA1的SUMO修饰,并且是细胞中BRCA1泛素连接酶活性所必需的。 BRCA1 / BARD1异二聚体的体外SUMO修饰大大提高了其连接酶活性,将其鉴定为SUMO调节的泛素连接酶(SRUbL)。此外,在RNF8累积后,PIAS SUMO连接酶是双链DNA(dsDNA)损伤修复蛋白的完全积累,以及熟练的双链断裂修复所必需的。这些数据表明SUMOylation途径在哺乳动物DNA损伤反应中起重要作用。

著录项

  • 来源
    《Nature》 |2009年第7275期|886-890|共5页
  • 作者单位

    Department of Medical and Molecular Genetics, King's College London, Guy's Medical School Campus, London SE1 9RT, UK;

    MRC Virology Unit, Church Street, Glasgow G11 5JR, Scotland, UK;

    Richard Dimbleby Department of Cancer Research, Randall Division of Cell and Molecular Biophysics, King's College London, Guy's Medical School Campus, London SE1;

    Department of Medical and Molecular Genetics, King's College London, Guy's Medical School Campus, London SE1 9RT, UK;

    Department of Medical and Molecular Genetics, King's College London, Guy's Medical School Campus, London SE1 9RT, UK;

    Department of Medical and Molecular Genetics, King's College London, Guy's Medical School Campus, London SE1 9RT, UK;

    Department of Medical and Molecular Genetics, King's College London, Guy's Medical School Campus, London SE1 9RT, UK;

    The Wellcome Trust/Cancer Research UK Gurdon Institute and Department of Zoology, University of Cambridge, Tennis Court Road, Cambridge CB2 1QN, UK;

    Department of Medical and Molecular Genetics, King's College London, Guy's Medical School Campus, London SE1 9RT, UK;

    Richard Dimbleby Department of Cancer Research, Randall Division of Cell and Molecular Biophysics, King's College London, Guy's Medical School Campus, London SE1 1UL, UK;

    Richard Dimbleby Department of Cancer Research, Randall Division of Cell and Molecular Biophysics, King's College London, Guy's Medical School Campus, London SE1 1UL, UK;

    Department of Medical and Molecular Genetics, King's College London, Guy's Medical School Campus, London SE1 9RT, UK;

  • 收录信息 美国《科学引文索引》(SCI);美国《工程索引》(EI);美国《生物学医学文摘》(MEDLINE);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-18 02:55:41

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号